News | Women's Health | October 04, 2019

The company celebrates recent portfolio expansion to address the entire continuum of breast cancer diagnosis and care

Hologic, Inc.’s Company’s Chairman, President and Chief Executive Officer Steve MacMillan, joined a number of employees to ring the Nasdaq Opening Bell for the 14th consecutive year on Oct. 2

Hologic, Inc.’s Company’s Chairman, President and Chief Executive Officer Steve MacMillan, joined a number of employees to ring the Nasdaq Opening Bell for the 14th consecutive year on Oct. 2 to mark the start of Breast Cancer Awareness Month.

Hologic has expanded its product portfolio significantly in recent months through insight-driven innovation and strategic acquisitions to address the entire continuum of breast cancer diagnosis and care. From tomosynthesis to ultrasound, to digital specimen radiography and stereotactic breast biopsy systems, to breast biopsy markers and surgical guidance systems — Hologic’s comprehensive suite of products is designed to meet the needs of radiologists, pathologists, breast surgeons and patients.

“As the world leader in mammography and a company focused on women’s health, we’re committed to early detection, more certain diagnoses, and accurate and compassionate treatment for women facing breast cancer,” said MacMillan. “We’re proud to recognize Breast Cancer Awareness Month by ringing the Nasdaq Opening Bell for the 14th year in a row, and we’re grateful to be joined by many of the dedicated employees whose passion fuels the work we do.”

Hologic’s participation in the Nasdaq opening bell ceremony was aired live at https://new.livestream.com/NASDAQ/live and with closed captioning on the Nasdaq MarketSite tower in Times Square. The video of the ceremony will be archived for one year on the Nasdaq site.

For more information: www.hologic.com


Related Content

News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Mammography

June 30, 2026 — The Food and Drug Administration has cleared new contrast-enhanced mammography (CEM) and CEM biopsy ...

Time June 30, 2026
arrow
News | Mammography

June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...

Time June 24, 2026
arrow
News | Women's Health

June 2, 2026 — Results of an American College of Radiology-managed retrospective study involving 110,000 women presented ...

Time June 02, 2026
arrow
News

May 21, 2026 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 22, 2026
arrow
News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
News | Women's Health

April 16, 2026 – GE HealthCare has expanded its collaboration with DeepHealth, Inc., a wholly-owned subsidiary of RadNet ...

Time April 20, 2026
arrow
News | Breast Imaging

April 15, 2026 — QT Imaging Holdings, Inc. has launched its QTI Imaging-Olea Viewer, developed in collaboration with ...

Time April 15, 2026
arrow
News | Breast Imaging

April 1, 2026 — QT Imaging Holdings has released its latest image reconstruction software update, version 4.5.0. This ...

Time April 02, 2026
arrow
News | Ultrasound Imaging

March 30, 2026 — Butterfly Network, Inc. has received clearance from the U.S. Food and Drug Administration (FDA) for a ...

Time April 01, 2026
arrow
Subscribe Now